United States · Investor

Aberdare Ventures

Last cheque observed Sep 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietVC firm

SeedSeries ASeries BWell-beingConnected HealthLongevity

Cheques on record
0%of best year0cheques in 12 months, 53 on record
Since the last cheque2978days00hrs00min00sec
Median round$19MCheque size, as they say$500K – $15MRounds led0 of 53Sole investor1 roundsExits5 from the portfolioMostly inUnited States, 98%
Pitch Aberdare Ventures

Aberdare Ventures highlights

  1. 01

    53 rounds on record

  2. 02

    Mostly Series B and Venture: 51% of its rounds

  3. 03

    Sole investor in 1 rounds, median $2.0M

  4. 04

    5 exits from the portfolio

What they do

Aberdare Ventures is the leading venture capital firm focused exclusively on transformational companies that enable more efficient, less costly, smarter healthcare.From their own website
Type
VC firm (from a list, unverified)
Cheque size
$500K – $15M as they say
Stages
SeedSeries ASeries BGrowth
Sectors
Well-beingConnected HealthLongevity
Based in
San Francisco, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first53 appearances

  1. 2018

    1 round

  2. Sept
    Cricket HealthSeries A · US · FinSMEs$24MWith 10 others
  3. 2016

    1 round

  4. Jul
    GravieSeries C · US · FinSMEs$14MWith 2 others
  5. 2015

    5 rounds

  6. Jun
    Autonomic TechnologiesSeries D · US$43MWith 7 others
  7. May
    JiffSeries C · US$23MWith 4 others
  8. May
    Autonomic TechnologiesSeries D · US$38MWith 4 others
  9. Apr
    GravieSeries B · US$13MWith 2 others
  10. Jan
    goBaltoSeries C · US$12MWith 4 others
  11. 2014

    3 rounds

  12. Sept
    JiffSeries B · US$18MWith 2 others
  13. Mar
    GravieSeries A · US$11MWith 2 others
  14. Mar
    goBaltoVenture · US$5.0MWith 3 others
  15. 2013

    3 rounds

  16. Sept
    ADVANCE MedicalGrowth · US · pehub.com$20MWith 2 others
  17. Apr
    Cervel NeurotechVenture · US · marketwire.com$14MWith 1 other
  18. Feb
    AviirSeries B · US · finsmes.com$10MWith 3 others
  19. 2012

    9 rounds

  20. Dec
    goBaltoSeries B · US · freshnews.com$12MWith 3 others
  21. Dec
    MC10Series C · US · mc10inc.com$10MWith 6 others
  22. Nov
    WelloSeed · US · techcrunch.com$1.0MWith 6 others
  23. Oct
    Kit CheckSeed · US$100KWith 4 others
  24. Sept
    RxAnteSeries A · US · prnewswire.comUndisclosedWith 1 other
  25. May
    Sonitus TechnologiesVenture · CA · sec.gov$34KWith 3 others
  26. Mar
    HemaQuest PharmaceuticalsSeries B · US · hemaquest.com$13MWith 4 others
  27. Mar
    JiffSeries A · US · freshnews.com$7.5MWith 2 others
  28. Jan
    MC10Venture · US · masshightech.com$2.0MSole investor
  29. 2011

    8 rounds

  30. Dec
    Omada HealthSeed · US · techcrunch.com$800KWith 5 others
  31. Dec
    AviirSeries B · US · pehub.com$10MWith 3 others
  32. Oct
    Autonomic TechnologiesSeries C · US · fis.dowjones.com$32MWith 3 others
  33. Oct
    NxTheraSeries B · US · fis.dowjones.com$22MWith 2 others
  34. Jul
    NevroVenture · US · finsmes.com$58MWith 6 others
  35. Jun
    AviirVenture · US · sec.gov$3.0MWith 2 others
  36. Feb
    Conatus PharmaceuticalsSeries B · US · pharmalive.com$20MWith 5 others
  37. Jan
    Rock HealthGrant · US · techcrunch.com$500KWith 5 others
  38. 2010

    3 rounds

  39. Dec
    JiffSeed · US$1.0MWith 1 other
  40. Apr
    HemaQuest PharmaceuticalsSeries B · US · fiercebiotech.com$12MWith 3 others
  41. Jan
    AviirVenture · US · deals.venturebeat.com$4.2MWith 2 others
  42. 2009

    6 rounds

  43. Oct
    AviirVenture · US · venturebeat.com$1.0MWith 2 others
  44. Aug
    AviirVenture · US · sec.gov$1.0MWith 2 others
  45. May
    Clovis OncologyGrowth · US$145MWith 6 others
  46. May
    Clovis OncologySeries A · US · onbiovc.com$145MWith 6 others
  47. Apr
    Posit ScienceSeries C · US · venturebeat.com$5.6MWith 2 others
  48. Jan
    Anacor PharmaceuticalSeries E · US · bio-medicine.org$50MWith 5 others
  49. 2008

    1 round

  50. Dec
    AviirVenture · US · venturebeat.com$7.8MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

PHPaul Henry KlingensteinManaging MemberiForm ADV

We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$29Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Aberdare Management Company, LLC
SEC number
CRD 163520

Exits from the portfolio

Companies it backed that were later bought or listed5 in all

Conatus PharmaceuticalsListed$69MJun 2013
KAI PharmaceuticalsBought by Amgen$315MApr 2012
Clovis OncologyListed$130MNov 2011
Anacor PharmaceuticalListedUndisclosedDec 2010
Ablation FrontiersBought by MedtronicUndisclosedFeb 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Aberdare Ventures. A count of rooms they were both in, not a relationship either has claimed.

Bay City CapitalVC firm13rounds togetherNew Leaf Venture PartnersVC firm8rounds togetherInterWest PartnersVC firm5rounds togetherKleiner Perkins Caufield & ByersVC firm5rounds togetherVenrockVC firm5rounds togetherNovartis Venture FundCorporate VC4rounds togetherVersant VenturesVC firm4rounds togetherAbingworthVC firm3rounds togetherAeris CapitalGrowth equity3rounds togetherArboretum VenturesVC firm3rounds togetherDe Novo VenturesGrowth equity3rounds togetherFrazier Healthcare PartnersPrivate equity3rounds together

Recently backed

The latest companies Aberdare Ventures put money into.

Cricket Health$24M · Sept 2018Gravie$14M · Jul 2016

Quick answers about Aberdare Ventures

What does Aberdare Ventures invest in?

Aberdare Ventures invests most often at Series B and Venture (51% of the rounds on record), in sectors such as Well-being, Connected Health and Longevity.

How active is Aberdare Ventures?

53 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2018.

What has Aberdare Ventures invested in recently?

Its most recent investments on record: Cricket Health (Series A, Sept 2018) and Gravie (Series C, Jul 2016).

How big are Aberdare Ventures's cheques?

The median round it joins is $19M. It says it writes cheques of $500K to $15M.

Does Aberdare Ventures lead rounds?

Rarely, if at all: none of its 53 investments on record names it as the lead.

Where does Aberdare Ventures invest?

Most of the companies it backs are in the United States (98%).

Is Aberdare Ventures investing now?

No investments in the last 12 months; the latest was in Sept 2018.

Who does Aberdare Ventures invest alongside?

Most often Bay City Capital (13 rounds together), New Leaf Venture Partners (8 rounds together) and InterWest Partners (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it